Philip Howard
PhD
Vice President, Chemistry
👥Biography 个人简介
Philip Howard is a medicinal chemist who pioneered pyrrolobenzodiazepine (PBD) dimer payloads for antibody-drug conjugates. His work on PBD warheads enabled the development of loncastuximab tesirine and other clinical-stage ADCs with enhanced potency against resistant tumors. He continues to innovate in linker-payload chemistry to improve ADC therapeutic windows.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Philip Howard 的研究动态
Follow Philip Howard's research updates
留下邮箱，当我们发布与 Philip Howard（AstraZeneca (formerly Spirogen/ADC Therapeutics)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment